Latest Birchview Capital, LP Stock Portfolio
Birchview Capital, LP Performance:
2025 Q1: -4.39%YTD: -4.39%2024: 4.06%
Performance for 2025 Q1 is -4.39%, and YTD is -4.39%, and 2024 is 4.06%.
About Birchview Capital, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Birchview Capital, LP reported an equity portfolio of $115.2 Millions as of 31 Mar, 2025.
The top stock holdings of Birchview Capital, LP are BMY, CORT, ACAD. The fund has invested 36.3% of it's portfolio in BRISTOL-MYERS SQUIBB CO and 6.6% of portfolio in CORCEPT THERAPEUTICS INC.
The fund managers got completely rid off SAREPTA THERAPEUTICS INC (SRPT), BIOHAVEN PHARMACEUTICAL HOLDING CO LTD and COHERUS BIOSCIENCES INC (CHRS) stocks. They significantly reduced their stock positions in ALPHATEC HOLDINGS INC (ATEC), MASIMO CORP (MASI) and UNITED THERAPEUTICS CORP (UTHR). Birchview Capital, LP opened new stock positions in ORTHOPEDIATRICS CORP (KIDS), SOLID BIOSCIENCES INC (SLDB) and APOGEE THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to UNIQURE NV (QURE), XENON PHARMACEUTICALS INC (XENE) and ARVINAS INC (ARVN).
The top stock holdings of Birchview Capital, LP are BMY, CORT, ACAD. The fund has invested 36.3% of it's portfolio in BRISTOL-MYERS SQUIBB CO and 6.6% of portfolio in CORCEPT THERAPEUTICS INC.
The fund managers got completely rid off SAREPTA THERAPEUTICS INC (SRPT), BIOHAVEN PHARMACEUTICAL HOLDING CO LTD and COHERUS BIOSCIENCES INC (CHRS) stocks. They significantly reduced their stock positions in ALPHATEC HOLDINGS INC (ATEC), MASIMO CORP (MASI) and UNITED THERAPEUTICS CORP (UTHR). Birchview Capital, LP opened new stock positions in ORTHOPEDIATRICS CORP (KIDS), SOLID BIOSCIENCES INC (SLDB) and APOGEE THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to UNIQURE NV (QURE), XENON PHARMACEUTICALS INC (XENE) and ARVINAS INC (ARVN).
Birchview Capital, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Birchview Capital, LP made a return of -4.39% in the last quarter. In trailing 12 months, it's portfolio return was 1.43%.
New Buys
| Ticker | $ Bought |
|---|---|
| orthopediatrics corp | 492,600 |
| solid biosciences inc | 476,442 |
| apogee therapeutics inc | 298,880 |
| compass therapeutics inc | 45,600 |
New stocks bought by Birchview Capital, LP
Additions
| Ticker | % Inc. |
|---|---|
| uniqure nv | 343 |
| xenon pharmaceuticals inc | 110 |
| scholar rock holding corp | 100 |
| moonlake immunotherapeutics | 100 |
| arvinas inc | 100 |
| neuropace inc | 64.42 |
| axsome therapeutics inc | 50.00 |
| tela bio inc | 24.00 |
Additions to existing portfolio by Birchview Capital, LP
Reductions
| Ticker | % Reduced |
|---|---|
| alphatec holdings inc | -43.1 |
| masimo corp | -26.18 |
| united therapeutics corp | -25.00 |
| acadia pharmaceuticals inc | -22.16 |
| axogen inc | -18.27 |
| springworks therapeutics inc | -17.2 |
| corcept therapeutics inc | -10.81 |
| travere therapeutics inc | -6.76 |
Birchview Capital, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| coherus biosciences inc | -113,160 |
| cero therapeutics holdings inc | -778 |
| biohaven pharmaceutical holding co ltd | -275,083 |
| sarepta therapeutics inc | -425,565 |
Birchview Capital, LP got rid off the above stocks
Sector Distribution
Birchview Capital, LP has about 92.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 92.9 |
| Others | 3.6 |
| Energy | 3.5 |
Market Cap. Distribution
Birchview Capital, LP has about 44.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 44.7 |
| SMALL-CAP | 23.5 |
| MID-CAP | 22.2 |
| MICRO-CAP | 5.6 |
| NANO-CAP | 2.9 |
Stocks belong to which Index?
About 78.2% of the stocks held by Birchview Capital, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 40.3 |
| S&P 500 | 37.9 |
| Others | 21.8 |
Birchview Capital, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Birchview Capital, LP
Birchview Capital, LP has 68 stocks in it's portfolio. About 66.1% of the portfolio is in top 10 stocks. BDSX proved to be the most loss making stock for the portfolio. CORT was the most profitable stock for Birchview Capital, LP last quarter.
Last Reported on: 15 May, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| BMY | bristol-myers squibb co | 36.29 | 685,192 | 41,789,800 | added | 0.00 | ||
Historical Trend of BRISTOL-MYERS SQUIBB CO Position Held By Birchview Capital, LPWhat % of Portfolio is BMY?:Number of BMY shares held:Change in No. of Shares Held: | ||||||||
| CORT | corcept therapeutics inc | 6.55 | 66,000 | 7,538,520 | reduced | -10.81 | ||
| ACAD | acadia pharmaceuticals inc | 3.80 | 263,400 | 4,375,070 | reduced | -22.16 | ||
| PRTA | prothena corp plc | 3.58 | 332,974 | 4,120,550 | added | 9.32 | ||
| BDSX | biodesix inc | 3.11 | 5,736,110 | 3,586,220 | added | 2.78 | ||
| NBIX | neurocrine biosciences inc | 2.90 | 30,240 | 3,344,540 | unchanged | 0.00 | ||
| AZYO | elutia inc | 2.61 | 1,187,740 | 3,004,970 | reduced | -3.08 | ||
| AXGN | axogen inc | 2.59 | 161,000 | 2,978,500 | reduced | -18.27 | ||
| PHR | phreesia inc | 2.55 | 114,700 | 2,931,730 | unchanged | 0.00 | ||
| TVTX | travere therapeutics inc | 2.15 | 138,000 | 2,472,960 | reduced | -6.76 | ||
| QDEL | quidelortho corp | 2.05 | 67,619 | 2,364,640 | unchanged | 0.00 | ||
| PTGX | protagonist therapeutics inc | 2.02 | 48,002 | 2,321,380 | added | 0.00 | ||
| UTHR | united therapeutics corp | 2.01 | 7,500 | 2,312,020 | reduced | -25.00 | ||
| DCGO | docgo inc | 1.98 | 864,062 | 2,281,120 | added | 13.09 | ||
| OVV | ovintiv inc | 1.94 | 52,200 | 2,234,160 | unchanged | 0.00 | ||
| HROW | harrow health inc | 1.68 | 72,910 | 1,939,410 | unchanged | 0.00 | ||
| MASI | masimo corp | 1.63 | 11,280 | 1,879,250 | reduced | -26.18 | ||
| EQT | eqt corporation | 1.61 | 34,619 | 1,849,690 | unchanged | 0.00 | ||
| CSTL | castle biosciences inc | 1.54 | 88,404 | 1,769,850 | added | 13.34 | ||
| ALKS | alkermes plc | 1.43 | 50,000 | 1,651,000 | unchanged | 0.00 | ||
